HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by MEIJS-ROELOFS, H. M. A. Articles by GRIBLING-HEGGE, L. Search for Related Content PubMed PubMed Citation Articles by MEIJS-ROELOFS, H. M. A. Articles by GRIBLING-HEGGE, L.

A possible role of 5-androstane-3,17β-diol (3-androstanediol) in the control of FSH secretion was studied at various ages in ovariectomized rats. In the rat strain used, vaginal opening, coincident with first ovulation, generally occurs between 37 and 42 days of age. If 3-androstanediol alone was given as an ovarian substitute, an inhibitory effect on FSH release was evident with all three doses tested (50, 100, 300 µg/100 g body wt) between 13 and 30 days of age; at 33–35 days of age only the 300 µg dose caused some inhibition of FSH release. Results were more complex if 3-androstanediol was given in combined treatment with oestradiol and progesterone. Given with progesterone, 3-androstanediol showed a synergistic inhibitory action on FSH release between 20 and 30 days of age. However, when 3-androstanediol was combined with oestradiol a clear decrease in effect, as compared to the effect of oestradiol alone, was found between 20 and 30 days of age. Also the effect of combined oestradiol and progesterone treatment was greater than the effect of combined treatment with oestradiol, progesterone and 3-androstanediol. At all ages after day 20 none of the steroid combinations tested was capable of maintaining FSH levels in ovariectomized rats similar to those in intact rats.

It is concluded that 3-androstanediol might play a role in the control of FSH secretion in the immature rat, but after day 20 the potentially inhibitory action of 3-androstanediol on FSH secretion is limited in the presence of oestradiol.